These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 6154660)
1. Lymphoma development from transplanted murine leukemia virus infected organ cultured thymuses: inhibitory effect of in vitro interferon treatment. Riesenfeld I; Tufveson G; Alm GV Int J Cancer; 1980 Apr; 25(4):529-34. PubMed ID: 6154660 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous and induced appearance of murine leukemia virus antigen containing cells in organ cultures of embryonic mouse thymus. Riesenfeld I; Alm GV Int J Cancer; 1977 Aug; 20(2):309-17. PubMed ID: 70415 [TBL] [Abstract][Full Text] [Related]
3. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus. Stockert E; O'Donnell PV; Obata Y; Old LJ Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3720-4. PubMed ID: 6251478 [TBL] [Abstract][Full Text] [Related]
5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
6. Role of the thymus in generation of lymphocyte functions. I. Demonstration of lymphocytes reactive to mitogens and allogeneic cells in the embryonic mouse thymus in organ culture. Tufveson G; Juhlin R; Steineck G; Alm GV Scand J Immunol; 1976; 5(8):901-7. PubMed ID: 136742 [TBL] [Abstract][Full Text] [Related]
7. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens. Cerny J; Hensgen PA; Fistel SH; Demler LM Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288 [TBL] [Abstract][Full Text] [Related]
8. [The type specific antigen of Gross leukemia virus in tumors and normal tissues and its identification by immunodiffusion methods]. Lezhneva OM Biull Eksp Biol Med; 1976 Feb; 81(2):217-9. PubMed ID: 819062 [TBL] [Abstract][Full Text] [Related]
9. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV. O'Donnell PV; Nowinski RC; Stockert E Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096 [No Abstract] [Full Text] [Related]
10. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV). Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus. Fischinger PJ; Dunlop NM; Robey WG Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):241-51. PubMed ID: 2982768 [TBL] [Abstract][Full Text] [Related]
12. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV. Coppola MA; Green WR; Rich RF Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627 [TBL] [Abstract][Full Text] [Related]
14. Virus expression and immunoprophylaxis of a murine lymphoma. Sekine I; Vredevoe DL; Hays EF J Natl Cancer Inst; 1975 Mar; 54(3):727-31. PubMed ID: 164567 [TBL] [Abstract][Full Text] [Related]
15. Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Kawashima K; Ikeda H; Hartley JW; Stockert E; Rowe WP; Old LJ Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4680-4. PubMed ID: 188051 [TBL] [Abstract][Full Text] [Related]
16. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon. Bekesi JG; Roboz JP; Zimmerman E; Holland JF Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796 [TBL] [Abstract][Full Text] [Related]
17. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness. Smith PM; Rich RF; Green WR Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425 [TBL] [Abstract][Full Text] [Related]
18. Prevention of T-cell lymphoma in AKR/J mice. Peled A; Haran-Ghera N Leukemia; 1988 Dec; 2(12 Suppl):125S-131S. PubMed ID: 2848990 [TBL] [Abstract][Full Text] [Related]
19. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. Green WR; Nowinski RC; Henney CS J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575 [TBL] [Abstract][Full Text] [Related]
20. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]